J14 - Moligand™,≥97% , CAS No.1043854-13-2

CAS: 1043854-13-2 Cat. No.: J651908 Summenformel: C28H25ClN4O2S Molekulargewicht: 517.04
Zu bestellen verfügbar
QUALITÄT & REINHEIT Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥97%
Synonyms
4-(((4-(4-(2-Chlorophenyl)piperazin-1-yl)-6-phenylpyrimidin-2-yl)thio)methyl)benzoic acid
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Größe
Deutschland (EU)
USA*
Preis
Menge
1mg
J651908-1mg
Auf Bestellung · 8–12 Wochen
25,95€
5mg
J651908-5mg
Auf Bestellung · 8–12 Wochen
48,51€
25mg
J651908-25mg
Auf Bestellung · 8–12 Wochen
112,72€
100mg
J651908-100mg
Auf Bestellung · 8–12 Wochen
286,27€
Enter a quantity for the sizes you want to add.

Übersicht

J14 is a reversible sulfiredoxin inhibitor with an IC50 of 8.1 μM. J14 induces oxidative stress (intracellular ROS accumulation) by inhibiting sulfiredoxin, leading to cytotoxicity and cancer cell death.

Spezifikationen

Synonyme
4-(((4-(4-(2-Chlorophenyl)piperazin-1-yl)-6-phenylpyrimidin-2-yl)thio)methyl)benzoic acid
Spezifikationen & Reinheit
Moligand™,≥97%
Storage
Store at -20°C
Verschickt in
Ice chest + Ice pads
Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.
Note
Moligand™
Aktionsart
ACTIVATOR
Reinheit
≥97%
Namen und Kennungen
Kanonisches Lächeln
C1CN(CCN1C2=CC=CC=C2Cl)C3=NC(=NC(=C3)C4=CC=CC=C4)SCC5=CC=C(C=C5)C(=O)O
IUPAC Name
4-[[4-[4-(2-chlorophenyl)piperazin-1-yl]-6-phenylpyrimidin-2-yl]sulfanylmethyl]benzoic acid
InChIKey
RSHUJZXWKLIBRE-UHFFFAOYSA-N
INCHI
1S/C28H25ClN4O2S/c29-23-8-4-5-9-25(23)32-14-16-33(17-15-32)26-18-24(21-6-2-1-3-7-21)30-28(31-26)36-19-20-10-12-22(13-11-20)27(34)35/h1-13,18H,14-17,19H2,(H,34,35)
Isomere SMILES
C1CN(CCN1C2=CC=CC=C2Cl)C3=NC(=NC(=C3)C4=CC=CC=C4)SCC5=CC=C(C=C5)C(=O)O
Molekulargewicht
517.04

Erweiterte Daten

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
KlasseDiazines
SubclassPyrimidines and pyrimidine derivatives
Intermediate Tree Nodes Not available
Direct ParentPhenylpyrimidines
Alternative Parents Phenylpiperazines  N-arylpiperazines  Benzoic acids  Aniline and substituted anilines  Dialkylarylamines  Benzoyl derivatives  Alkylarylthioethers  Aminopyrimidines and derivatives  Chlorobenzenes  Imidolactams  Aryl chlorides  Heteroaromatic compounds  Amino acids  Sulfenyl compounds  Azacyclic compounds  Carboxylic acids  Organic oxides  Hydrocarbon derivatives  Organooxygen compounds  Organochlorides  
Molecular FrameworkAromatic heteromonocyclic compounds
Substituents Phenylpiperazine - 4-phenylpyrimidine - N-arylpiperazine - Benzoic acid or derivatives - Benzoic acid - Aryl thioether - Benzoyl - Dialkylarylamine - Aniline or substituted anilines - Aminopyrimidine - Alkylarylthioether - Chlorobenzene - Halobenzene - Imidolactam - Benzenoid - 1,4-diazinane - Monocyclic benzene moiety - Piperazine - Aryl halide - Aryl chloride - Heteroaromatic compound - Amino acid - Amino acid or derivatives - Tertiary amine - Carboxylic acid derivative - Thioether - Carboxylic acid - Sulfenyl compound - Azacycle - Hydrocarbon derivative - Organohalogen compound - Organochloride - Amine - Organic nitrogen compound - Organonitrogen compound - Organooxygen compound - Organosulfur compound - Organic oxygen compound - Organic oxide - Aromatic heteromonocyclic compound
BeschreibungThis compound belongs to the class of organic compounds known as phenylpyrimidines. These are polycyclic aromatic compounds containing a benzene ring linked to a pyrimidine ring through a CC or CN bond. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions.
External Descriptors Not available
3D-Struktur
Interaktives chemisches Strukturmodell





Zertifikate (CoA, COO, BSE/TSE und Analyse-Diagramm)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

5 results found

Lot NumberCertificate TypeDatumArtikel
I2604733I2604733Certificate of AnalysisMar 30, 2026 J651908
I2604734I2604734Certificate of AnalysisMar 30, 2026 J651908
I2604735I2604735Certificate of AnalysisMar 30, 2026 J651908
I2604736I2604736Certificate of AnalysisMar 30, 2026 J651908
I2609237I2609237Certificate of AnalysisMar 30, 2026 J651908
Chemische und physikalische Eigenschaften
LöslichkeitDMSO : ≥ 125 mg/mL (241.76 mM)
Molekulargewicht517.000 g/mol
XLogP36.400
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count7
Rotatable Bond Count7
Exact Mass516.139 Da
Monoisotopic Mass516.139 Da
Topological Polar Surface Area94.900 Ų
Heavy Atom Count36
Formal Charge0
Complexity695.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Lösungsrechner
Bewertungen

Kundenbewertungen

Application Protocols

No vendor-validated application protocols are provided for J14. The following general procedures are commonly used for small-molecule screening compounds and may be adapted as needed.

  • Stock preparation

    • Warm to room temperature in a desiccator before opening. Weigh quickly to minimize moisture uptake.
    • Dissolve in anhydrous DMSO to 10–50 mM. Vortex and sonicate if necessary. If insoluble, try DMF or EtOH.
    • Sterile-filter (0.2 µm PTFE) for cell-adjacent assays where sterility is critical.
    • Aliquot into low-bind tubes or 96-/384-well source plates; store at −20 °C or below.
  • Assay dilution

    • Prepare intermediate dilutions in DMSO or ACN to minimize precipitation upon aqueous addition.
    • Keep final organic solvent constant across controls and samples (e.g., 0.5% DMSO v/v).
  • Analytical QC (recommended)

    • LC-MS: C18, water/ACN + 0.1% formic acid, 5–95% gradient, 5–10 min; verify single dominant peak and correct m/z.
    • Optional: 1H NMR (quick screen) to confirm integrity after storage.

These steps are general guidance only; adjust to your assay, instrumentation, and institutional SOPs.

Biological Roles

J14 is provided as a research small molecule (Moligand) with no disclosed endogenous or physiological role.

  • Endogenous function: None assigned; it is a synthetic compound. Any biological interactions would be context- and target-dependent and must be determined empirically.
  • Use in biochemistry (general):
    • As a putative ligand or probe candidate in in vitro assays (enzyme inhibition, receptor binding, protein–ligand biophysics).
    • For orthogonal target validation using DSF, ITC, MST, or SPR, provided solubility and stability are adequate under assay conditions.
  • ADME/biophysical characterization (general guidance): If required, determine solubility (kinetic/thermodynamic), permeability surrogates (PAMPA), and plasma protein binding in small-scale studies to inform assay design. These are not provided for this item and must be experimentally measured.

No clinical or therapeutic claims are made or implied. For any biological testing, ensure appropriate controls (vehicle, positive/negative reference ligands) and monitor for assay interference (aggregation, redox cycling, fluorescence quenching) that may confound interpretation.

Buffer Applications

This product is not a buffering agent. However, buffers are commonly used as vehicles for assays involving small molecules.

Practical notes for preparing assay buffers (general):

  • Maintain a consistent DMSO percentage across all wells/samples (e.g., 0.1–1.0% v/v) to control solvent effects.
  • Common buffers: HEPES (pH 7.0–7.5), PBS (pH 7.2–7.4), or Tris (pH 7.5–8.0), selected to suit the biological target. Include 0.01–0.05% nonionic surfactant (e.g., Tween 20) if colloidal aggregation is a risk.
  • Filter (0.22 µm) and degas buffers for optical/biophysical assays to reduce noise and bubble artifacts.
  • For metal-sensitive targets, use chelator-free buffers; for metalloproteins, maintain appropriate cofactors.

Item-specific buffer compatibility is not specified; verify stability and solubility of J14 in your chosen buffer system before large experiments.

Green Alternatives

Without a disclosed structure, solvent and process choices are the main levers for greener handling of J14.

Comparison of common solvents for handling screening compounds (general, literature-based):

  • DMSO
    • Pros: Excellent solvency, water-miscible, stable frozen stocks.
    • Cons: High boiling point complicates removal; can carry over into waste streams.
  • Ethanol (EtOH)
    • Pros: Bio-derived routes available, readily biodegradable, low toxicity profile relative to many organics.
    • Cons: Lower solvency for hydrophobic scaffolds; volatility requires sealed handling.
  • Isopropanol (IPA)
    • Pros: Good compromise between solvency and green metrics; widely available.
    • Cons: May not dissolve highly lipophilic compounds at high concentration.
  • Acetonitrile (ACN)
    • Pros: LC-friendly; lower viscosity.
    • Cons: Petrochemical origin; toxicity and waste considerations.

Practical greener strategies:

  • Prefer EtOH/IPA for workups and cleaning when solubility allows; reserve DMSO/DMF for stock preparation only.
  • Minimize DMSO volume in biological assays (≤0.5% v/v when possible) to reduce environmental burden and assay artifacts.
  • Use micro-aliquots to extend shelf-life and prevent waste from freeze–thaw cycles.
  • Consolidate analytical runs (batch LC-MS) to reduce ACN consumption; consider water-rich gradients where chromatographically feasible.
Pharmaceutical Uses

J14 is provided strictly for research use only. No pharmacopeial status, excipient role, or clinical application is provided in the product data.

Typical non-clinical uses for such materials in drug discovery (general):

  • Analytical reference standard for LC-MS method development or retention-time locking within discovery projects.
  • Screening hit or tool compound candidate for in vitro characterization, SAR benchmarking, and selectivity panels.
  • Stability studies (chemical and photostability) to inform medicinal chemistry optimization.

No therapeutic claims are made or implied. If you require material conforming to GMP, compendial monographs, or with an established DMF, please contact us for suitability—this listing is not represented as GMP- or pharmacopeia-grade.

Physical Properties

Item-specific physicochemical properties are not disclosed in the current product data. Where values are required for method development, please consult the item’s CoA/Spec Sheet or SDS.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point (MP): Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling point (BP): Not specified for this item; refer to CoA/Spec Sheet.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Not specified for this item; refer to CoA/Spec Sheet. Practical note: screening compounds are commonly soluble in DMSO at 10–50 mM (general practice, literature) but verify experimentally.
  • logP/logD, pKa, refractive index: Not specified for this item; refer to CoA/Spec Sheet.

General guidance for undivulged solids (literature/practice):

  • Perform a tiered solubility screen: water, PBS pH 7.4 (0.1% DMSO), MeOH, EtOH, ACN, DMF, DMSO.
  • Assess hygroscopicity qualitatively by mass change upon ambient exposure; handle under dry conditions if mass drift is observed.
  • If lipophilic behavior is suspected (slow wetting, strong retention on C18), consider co-solvent systems (e.g., 2–5% DMSO or 0.5–1% Tween 80 in aqueous assays, if biologically acceptable).
  • For analytical methods, begin with reversed-phase C18, 5–95% water/ACN + 0.1% formic acid, UV scan 200–400 nm to identify λmax (general method development practice).
Quality and Grades
  • Grade/Purity: Moligand™

About Moligand (general description of line):

  • Moligand denotes curated small-molecule ligands intended for discovery workflows (screening, hit validation, assay development). These materials are typically quality-controlled for identity (e.g., HRMS/1H NMR) and purity (e.g., HPLC/UPLC), with packaging formats suitable for plate-based operations. Item-specific analytical values are provided on the CoA/Spec Sheet.

What this means for your lab:

  • Expect research-grade material appropriate for biochemical, biophysical, or cell-free assays. UV background, residual solvents, water content, and metal content are not specified here and should be checked on the CoA if relevant to your application.
  • If you require chromatography-ready material (e.g., LC-MS reference standard), request documentation of impurity profile and recommended detection wavelengths.
  • Stabilizers/inhibitors: Not specified for this item; refer to CoA/Spec Sheet.

Release documentation:

  • CoA with batch-specific purity and identification methods: consult the lot paperwork.
  • If your workflow requires orthogonal confirmation, we recommend quick-internal QC (LC-MS single run + 1H NMR snapshot) upon receipt to confirm fit-for-purpose purity for sensitive assays.
Reaction and Applications

Intended use (as supplied): J14 is a Moligand small molecule for research screening and probe-development workflows. No target or mechanism is specified in the product data.

Typical applications for such compounds (general, research use only):

  • Primary/secondary screening: Biochemical or biophysical binding assays (e.g., enzymatic inhibition assays, DSF/Thermal shift, MST, ITC) using DMSO stocks with controlled final concentrations of organic solvent.
  • Cell-free target engagement: SPR or BLI with immobilized protein to map KD/kon/koff when the compound structure/solubility allows.
  • Orthogonal profiling: LC-MS-based activity assays, NMR ligand-observe (WaterLOGSY, STD-NMR) to confirm binding.
  • Structure–activity relationship (SAR) development: Use J14 as a benchmark or seed for analog selection if structural series information is available from the CoA or supplier resources.

Practical tips:

  • Validate compound integrity by LC-MS before critical assays; impurities can confound readouts.
  • Titrate DMSO in assay buffers (0–2% v/v) to ensure tolerance and minimize false positives/negatives.
  • For fluorescence-based assays, pre-screen intrinsic fluorescence/absorbance of J14 to identify interference windows.
  • If precipitation occurs upon dilution into aqueous buffers, increase surfactant (e.g., 0.01–0.05% nonionic), raise temperature slightly (if assay-tolerant), or pre-dilute into a miscible solvent like ethanol before final aqueous addition.
Reaction Conditions

Item-specific reaction conditions are not applicable without a disclosed structure. If you intend to chemically modify J14 (user-driven activity), adopt a conservative screening approach:

  • Start with small-scale scouting (5–25 mg) to probe solubility and stability in common media (EtOH, MeOH, ACN, DCM, THF, DMF, DMSO).
  • Map stability across pH (2, 7, 10) at room temperature for 1–24 h to detect hydrolysis or rearrangements (LC-MS monitoring).
  • For coupling reactions (if functional handles are present), begin with mild bases (DIPEA, K2CO3) and room temperature to 60 °C, monitoring by LC-MS.
  • Oxidations/reductions should be attempted with chemoselective reagents (e.g., TEMPO for alcohol oxidations, NaBH4 for carbonyl reductions) only after functional groups are identified by spectroscopy.

These are general, literature-informed practices and may not be applicable to J14. No yields or specific conditions are claimed for this item.

Safety and Handling

Safety details specific to J14 are not provided in the product data and may be disclosed in the SDS.

  • GHS Classification: Not specified for this item; refer to SDS.
  • Signal Word / H-Statements / Pictograms: Not specified for this item; refer to SDS.

General laboratory precautions for research-use small molecules:

  • PPE: Lab coat, safety glasses, and appropriate chemical-resistant gloves (e.g., nitrile). Avoid inhalation of dusts/aerosols and contact with skin or eyes.
  • Engineering controls: Handle powders in a fume hood or ventilated enclosure. Use a balance enclosure when weighing fine solids.
  • First aid (general): Inhalation—move to fresh air; Skin—wash with soap/water; Eyes—rinse with water for several minutes; Ingestion—rinse mouth. Seek medical attention as per SDS guidance.
  • Incompatibilities: Until functional groups are known, avoid strong oxidizers/reducers, strong acids/bases, and reactive metals. Keep away from ignition sources if solvent is flammable.
  • Spill/cleanup: Avoid dust generation; collect with damp disposable towels or HEPA vacuum; dispose according to institutional hazardous waste procedures.
  • Waste: Treat as organic laboratory chemical waste; segregate halogenated from non-halogenated solvents if applicable.

Always consult the product-specific SDS for authoritative hazard, toxicological, and disposal information.

Solvent Selection

Because the exact structure is not disclosed here, solvent selection should follow best practices for screening compounds.

  • Primary stock solvent: DMSO (anhydrous) is the default for discovery libraries due to broad solvating power and assay compatibility up to 0.1–1% v/v (assay-dependent; literature practice). Prepare 10–50 mM master stocks, then aliquot.
  • Secondary solvents: DMF (for challenging solutes), ethanol or methanol (when biological compatibility is critical), or acetonitrile for analytical dilutions. Water solubility is unknown—use co-solvent strategies for aqueous work.
  • Miscibility profile (general):
    • DMSO: miscible with water and most organics; high boiling point facilitates storage but can complicate drying.
    • Ethanol/methanol: miscible with water; easier evaporation; biological tolerance varies.
    • Acetonitrile: miscible with water; LC-friendly; lower viscosity improves pipetting accuracy.

Comparison (general guidance):

  • Choose DMSO for maximum solubility and long-term frozen aliquots.
  • Choose EtOH/MeOH for rapid assay mixing and lower DMSO burden, provided solubility permits.
  • Choose ACN for LC/UPLC sample prep to minimize peak broadening; back-dilute into mobile phase.

Practical tips:

  • Run a quick solubility ladder (1, 5, 10, 25, 50 mM) at room temperature with vortex/sonication.
  • Filter 0.2 µm before HPLC/LC-MS to prevent injector fouling.
  • Record exact solvent lot and water content for reproducibility in biophysical assays.
Storage and Reconstitution
  • Storage Conditions (as provided): Store at −20 °C.
  • Shipping: Shipped in an ice chest with ice pads to maintain a cold chain.
  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.

Best practices for storage (general):

  • Protect from moisture and light. Keep container tightly closed under an inert atmosphere (e.g., nitrogen or argon) if feasible, especially for air/moisture-sensitive compounds.
  • Minimize freeze–thaw cycles: prepare single-use aliquots (10–100 µL) of concentrated DMSO stock (e.g., 10–50 mM) and store at −20 to −80 °C.
  • For solid material, allow vial to equilibrate to room temperature in a desiccator before opening to avoid condensation.

Reconstitution (general guidance):

  • Use anhydrous DMSO as first-line solvent. If higher aqueous compatibility is needed, prepare a DMSO concentrate and back-dilute into buffer with vigorous mixing to avoid precipitation.

  • Record final solvent composition in all experiments. If turbidity forms upon dilution, increase organic co-solvent slightly or warm gently (if assay-permissible).

  • Stability: Not specified for this item; refer to CoA/Spec Sheet for any shelf-life or retest date.

  • Research Use: For research use only.

Structure and Identity

Brief overview: J14 (SKU J651908) is supplied as a Moligand small-molecule screening compound. Item-specific structural identifiers are largely not disclosed in the product data.

  • Product Name: J14
  • SKU: J651908
  • CAS: 1043854-13-2
  • PubChem CID: 45987688
  • InChIKey: 324720 (as provided; note this is not in the typical hashed InChIKey format)
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.

Structural features (general guidance):

  • Functional groups, ring systems, and stereochemistry cannot be described without a disclosed structure. Consult the CoA/Spec Sheet or SDS for structural depiction.
  • For internal records, we recommend linking this SKU to your ELN entry with the CAS and CID to pull literature identifiers when available.

2D structure description:

  • Not available in the provided data. If a structure file (SDF/Mol) is supplied upon purchase, describe the core scaffold (e.g., heteroaromatic ring systems, linker length, H-bond donors/acceptors, stereocenters) to inform assay design and solubility planning.
Synthetic Utility

The primary intent of J14 is as a screening ligand (Moligand), not as a general synthetic reagent or building block. Since no structural information is disclosed here, specific transformations cannot be recommended.

General considerations if derivatization is planned (user-driven, not product-specified):

  • Confirm full structural assignment (1D/2D NMR, HRMS, IR) and assess reactive handles (e.g., halides, amines, acids) before planning synthetic routes.
  • If late-stage diversification (LSD) is desired for SAR expansion, consider mild cross-couplings (e.g., Buchwald–Hartwig, Suzuki–Miyaura) or amide couplings, contingent on functional group presence—these suggestions are general and may not apply to J14 without structural confirmation.
  • Protecting-group strategy and chemoselectivity must be established empirically once functional groups are known.

For most users, J14’s value lies in biochemical applications rather than as a precursor. Use this section only if you have obtained the structure and verified the feasibility of synthetic modifications.

Target Specificity
  • No target, epitope, or specificity information is provided for J14 in the product data.

This item is offered as a general small-molecule ligand for discovery workflows. Any target engagement, selectivity, or off-target profile must be determined empirically by the end user using appropriate assays (e.g., biochemical IC50/Ki, biophysical KD, or panel screening).

Häufig gestellte Fragen

What is the purity of this product?
This product is supplied at ≥97% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
What is Moligand??
Moligand? is one of Aladdin Scientific's premium product lines, formulated for high-purity applications across multiple workflows. Compared to standard grades in the same workflow, Moligand? products typically offer tighter specifications, more rigorous QC, and stronger lot-to-lot consistency.
How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 1043854-13-2, the molecular formula is C28H25ClN4O2S, and the molecular weight is 517.04 g/mol. InChIKey RSHUJZXWKLIBRE-UHFFFAOYSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Dürfen wir Sie über Rabattaktionen informieren?

Später erinnern

Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.

Hoppla! Benachrichtigungen sind deaktiviert.